Merck KGaA pursuing Springworks; BridgeBio wins EU drug OK

The German drugmaker confirmed acquisition talks, but cautioned a deal may not materialize. Elsewhere, Biohaven got priority review on a key drug and Third Harmonic restructured.

Pfizer launches cost savings program on TrumpRx lowering drug costs for millions of Americans

February 23, 2026

Novo cuts guidance, names new CEO as obesity drug challenges mount

Novo’s next-gen obesity shot fails to match Lilly drug in head-to-head study

February 23, 2026

Source link

Merck KGaA pursuing Springworks; BridgeBio wins EU drug OK

Pfizer launches cost savings program on TrumpRx lowering drug costs for millions of Americans

Novo’s next-gen obesity shot fails to match Lilly drug in head-to-head study

The D Brief: Air Force efforts, on hold; Desk deficits as workers return; Foreign-aid monitoring, slashed; It’s Fort Bragg again; And a bit more.

Kimtai, Lelmengit Discuss Healthcare Boost for Emgwen

Kimtai, Lelmengit Discuss Healthcare Boost for Emgwen

Leave a Reply Cancel reply

RECOMMENDED NEWS

Trend Micro and Zero&One establish a strategic cloud partnership at GITEX Global

Kenya introduces air ticket fee to strengthen its aviation and tourism ecosystem

Etihad Airways serves up double-daily trips for summer 2025

Chinese Startup 01.AI Is Winning the Open Source AI Race

POPULAR NEWS

Ghana to build three oil refineries, five petrochemical plants in energy sector overhaul

The world’s top 10 most valuable car brands in 2025

Top 10 African countries with the highest GDP per capita in 2025

Global ranking of Top 5 smartphone brands in Q3, 2024

When Will SHIB Reach $1? Here’s What ChatGPT Says

Merck KGaA pursuing Springworks; BridgeBio wins EU drug OK

Related posts

The D Brief: Air Force efforts, on hold; Desk deficits as workers return; Foreign-aid monitoring, slashed; It’s Fort Bragg again; And a bit more.

Kimtai, Lelmengit Discuss Healthcare Boost for Emgwen

Leave a Reply Cancel reply

RECOMMENDED NEWS

POPULAR NEWS